Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

AZ reports growth again in Q3, driven by oncology and China sales

AZ reports growth again in Q3, driven by oncology and China sales Another strong performance from our new medicines accompanied impressive results in our key markets, most notably in China, the US and Japan.

Novartis grows in Q3 thanks to stellar performance of key drugs

Novartis grows in Q3 thanks to stellar performance of key drugs The therapy is currently under regulatory review in Europe and Japan, with decisions expected in 2020. ... The FDA in the US is still investigating the data manipulation – Novartis CEO Vas Narasimhan (pictured below) has said however that “for both

Roche scores another FDA approval for Xofluza

Roche scores another FDA approval for Xofluza Roche holds worldwide rights to the drug, excluding Japan and Taiwan, which are retained exclusively by Shionogi.

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal UCB and Amgen now say they are hoping for an EMA approval before the end of the year, which will come after approvals for Evenity in the US and Japan earlier

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

Infographics